Northern Trust
PRCT icon

Northern Trust’s Procept Biorobotics PRCT Stock Holding History

Northern Trust’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.5M Buy
597,549
+45,531
+8% +$1.14M ﹤0.01% 2030
2026
Q1 		$13.8M Sell
552,018
-1,085
-0.2% -$30.6K ﹤0.01% 1899
2025
Q4 		$17.4M Buy
553,103
+56,653
+11% +$1.88M ﹤0.01% 1763
2025
Q3 		$17.7M Sell
496,450
-10,701
-2% -$489K ﹤0.01% 1770
2025
Q2 		$29.2M Buy
507,151
+74,204
+17% +$4.2M ﹤0.01% 1425
2025
Q1 		$25.2M Sell
432,947
-13,521
-3% -$923K ﹤0.01% 1488
2024
Q4 		$35.9M Buy
446,468
+60,098
+16% +$5.13M 0.01% 1329
2024
Q3 		$31M Buy
386,370
+27,621
+8% +$1.96M 0.01% 1349
2024
Q2 		$21.9M Sell
358,749
-7,675
-2% -$456K ﹤0.01% 1495
2024
Q1 		$18.1M Sell
366,424
-11,454
-3% -$545K ﹤0.01% 1654
2023
Q4 		$15.8M Buy
377,878
+25,741
+7% +$877K ﹤0.01% 1774
2023
Q3 		$11.6M Buy
352,137
+22,773
+7% +$776K ﹤0.01% 1895
2023
Q2 		$11.6M Buy
329,364
+90,200
+38% +$2.98M ﹤0.01% 1949
2023
Q1 		$6.79M Buy
239,164
+4,661
+2% +$164K ﹤0.01% 2277
2022
Q4 		$9.74M Buy
234,503
+5,419
+2% +$233K ﹤0.01% 2029
2022
Q3 		$9.5M Buy
229,084
+38,159
+20% +$1.52M ﹤0.01% 2007
2022
Q2 		$6.24M Buy
190,925
+125,953
+194% +$4.58M ﹤0.01% 2355
2022
Q1 		$2.27M Sell
64,972
-1,089
-2% -$26.2K ﹤0.01% 3036
2021
Q4 		$1.65M Buy
+66,061
New +$2.44M ﹤0.01% 3318

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Northern Trust's PRCT Position: Q2 2026 in Review

Northern Trust increased its Procept Biorobotics (PRCT) stake by 8.2% in Q2 2026, buying an estimated $1.14M and bringing the position to 597,549 shares worth $13.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2030.

Northern Trust first reported a position in PRCT in Q4 2021 and has held it in 19 quarters since. The position peaked at $35.9M in Q4 2024. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Northern Trust held 597,549 shares of Procept Biorobotics worth $13.5M as of Q2 2026.
  • Northern Trust bought 45,531 Procept Biorobotics shares in Q2 2026, an estimated $1.14M.
  • Procept Biorobotics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2030 holding.
  • Northern Trust first reported a position in Procept Biorobotics in Q4 2021 and has held it in 19 quarters since.
  • Northern Trust's Procept Biorobotics position peaked at $35.9M in Q4 2024.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.